These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1156 related articles for article (PubMed ID: 16083712)

  • 1. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution.
    Heller F; Florian P; Bojarski C; Richter J; Christ M; Hillenbrand B; Mankertz J; Gitter AH; Bürgel N; Fromm M; Zeitz M; Fuss I; Strober W; Schulzke JD
    Gastroenterology; 2005 Aug; 129(2):550-64. PubMed ID: 16083712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.
    Caruso R; Sarra M; Stolfi C; Rizzo A; Fina D; Fantini MC; Pallone F; MacDonald TT; Monteleone G
    Gastroenterology; 2009 Jun; 136(7):2270-9. PubMed ID: 19505427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.
    Manousou P; Kolios G; Drygiannakis I; Pyrovolaki K; Bourikas L; Papadaki HA; Kouroumalis E
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial tight junctions in intestinal inflammation.
    Schulzke JD; Ploeger S; Amasheh M; Fromm A; Zeissig S; Troeger H; Richter J; Bojarski C; Schumann M; Fromm M
    Ann N Y Acad Sci; 2009 May; 1165():294-300. PubMed ID: 19538319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients.
    Epple HJ; Schneider T; Troeger H; Kunkel D; Allers K; Moos V; Amasheh M; Loddenkemper C; Fromm M; Zeitz M; Schulzke JD
    Gut; 2009 Feb; 58(2):220-7. PubMed ID: 18936106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment.
    Zeissig S; Bojarski C; Buergel N; Mankertz J; Zeitz M; Fromm M; Schulzke JD
    Gut; 2004 Sep; 53(9):1295-302. PubMed ID: 15306588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response.
    Sato T; Nakai T; Tamura N; Okamoto S; Matsuoka K; Sakuraba A; Fukushima T; Uede T; Hibi T
    Gut; 2005 Sep; 54(9):1254-62. PubMed ID: 16099792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation.
    Jenkins D; Seth R; Kummer JA; Scott BB; Hawkey CJ; Robins RA
    J Pathol; 2000 Feb; 190(2):184-9. PubMed ID: 10657017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the novel Th17 cytokine IL-26 in intestinal inflammation.
    Dambacher J; Beigel F; Zitzmann K; De Toni EN; Göke B; Diepolder HM; Auernhammer CJ; Brand S
    Gut; 2009 Sep; 58(9):1207-17. PubMed ID: 18483078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis.
    Lampinen M; Backman M; Winqvist O; Rorsman F; Rönnblom A; Sangfelt P; Carlson M
    J Leukoc Biol; 2008 Dec; 84(6):1392-9. PubMed ID: 18801925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease.
    Matsuoka K; Inoue N; Sato T; Okamoto S; Hisamatsu T; Kishi Y; Sakuraba A; Hitotsumatsu O; Ogata H; Koganei K; Fukushima T; Kanai T; Watanabe M; Ishii H; Hibi T
    Gut; 2004 Sep; 53(9):1303-8. PubMed ID: 15306590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis.
    Olsen T; Goll R; Cui G; Husebekk A; Vonen B; Birketvedt GS; Florholmen J
    Scand J Gastroenterol; 2007 Nov; 42(11):1312-20. PubMed ID: 17852866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration.
    Brand S; Beigel F; Olszak T; Zitzmann K; Eichhorst ST; Otte JM; Diepolder H; Marquardt A; Jagla W; Popp A; Leclair S; Herrmann K; Seiderer J; Ochsenkühn T; Göke B; Auernhammer CJ; Dambacher J
    Am J Physiol Gastrointest Liver Physiol; 2006 Apr; 290(4):G827-38. PubMed ID: 16537974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease.
    Vetrano S; Rescigno M; Cera MR; Correale C; Rumio C; Doni A; Fantini M; Sturm A; Borroni E; Repici A; Locati M; Malesci A; Dejana E; Danese S
    Gastroenterology; 2008 Jul; 135(1):173-84. PubMed ID: 18514073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis.
    Tsukada Y; Nakamura T; Iimura M; Iizuka BE; Hayashi N
    Am J Gastroenterol; 2002 Nov; 97(11):2820-8. PubMed ID: 12425554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the expression of claudins in active ulcerative colitis.
    Oshima T; Miwa H; Joh T
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S146-50. PubMed ID: 19120888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth in epithelial cell proliferation and apoptosis correlates specifically to the inflammation activity of inflammatory bowel diseases: ulcerative colitis shows specific p53- and EGFR expression alterations.
    Sipos F; Molnár B; Zágoni T; Berczi L; Tulassay Z
    Dis Colon Rectum; 2005 Apr; 48(4):775-86. PubMed ID: 15747078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells.
    Pizarro TT; Michie MH; Bentz M; Woraratanadharm J; Smith MF; Foley E; Moskaluk CA; Bickston SJ; Cominelli F
    J Immunol; 1999 Jun; 162(11):6829-35. PubMed ID: 10352304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased T-helper 2 cytokines in bile from patients with IgG4-related cholangitis disrupt the tight junction-associated biliary epithelial cell barrier.
    Müller T; Beutler C; Picó AH; Otten M; Dürr A; Al-Abadi H; Guckelberger O; Meyer Zum Büschenfelde D; Jöhrens K; Volkmann M; Lankisch T; Voigtländer T; Anders M; Shibolet O; Jefferson DM; Podolsky DK; Fischer A; Veltzke-Schlieker W; Adler A; Baumgart DC; Sturm A; Wiedenmann B; Schott E; Berg T
    Gastroenterology; 2013 May; 144(5):1116-28. PubMed ID: 23391819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease.
    Zeissig S; Bürgel N; Günzel D; Richter J; Mankertz J; Wahnschaffe U; Kroesen AJ; Zeitz M; Fromm M; Schulzke JD
    Gut; 2007 Jan; 56(1):61-72. PubMed ID: 16822808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.